Couverture de Part 9: Pediatric Epilepsy Board Prep Q&A

Part 9: Pediatric Epilepsy Board Prep Q&A

Part 9: Pediatric Epilepsy Board Prep Q&A

Écouter gratuitement

Voir les détails

3 mois pour 0,99 €/mois

Après 3 mois, 9.95 €/mois. Offre soumise à conditions.

À propos de ce contenu audio

Summary

This episode of Child Neurology Board Review delves into various pediatric neurological disorders, focusing on Angelman syndrome, benign epilepsy with centrotemporal spikes, infantile spasms, temporal lobe epilepsy, and Dravet syndrome. Each condition is explored through case studies, highlighting symptoms, diagnosis, treatment options, and future directions in research and therapy.


Takeaways

  • Angelman syndrome is caused by the loss of function of the UB3A gene.
  • Patients with Angelman syndrome exhibit developmental delays and seizures.
  • Benign epilepsy with centrotemporal spikes is common in children and often resolves by age 18.
  • Hypsarrhythmia is a key EEG finding in infantile spasms.
  • Temporal lobe epilepsy can result from childhood febrile seizures.
  • Dravet syndrome is a severe genetic epilepsy disorder triggered by fever.
  • Avoid sodium channel blockers in Dravet syndrome as they worsen seizures.
  • Gene therapy is a promising future direction for genetic epilepsy disorders.
  • Early intervention and therapy are crucial for developmental outcomes.
  • Regular follow-up is essential for managing pediatric epilepsy.


Sound Bites

  • "This is Angelman syndrome."
  • "The diagnosis is Angelman syndrome."
  • "This is Dravet syndrome."

Chapters

00:00
Understanding Angelman Syndrome

02:50
Benign Epilepsy with Centrotemporal Spikes

05:23
West Syndrome: A Severe Infantile Epilepsy

08:07
Temporal Lobe Epilepsy and Its Implications

10:15
Dravet Syndrome: A Genetic Epilepsy Disorder

11:27
Silent Ocean

Les membres Amazon Prime bénéficient automatiquement de 2 livres audio offerts chez Audible.

Vous êtes membre Amazon Prime ?

Bénéficiez automatiquement de 2 livres audio offerts.
Bonne écoute !
    Aucun commentaire pour le moment